Mary Ann E Moore sold $130k of MD
EVP, GC, Chief Admin Off & Sec at Pediatrix Medical Group, Inc.. 8,108 shares at an average of $16.00, traded Nov 8, 2024, filed Nov 12, 2024.
Score components
- +15RoleOfficer
- +11Trade size$130k at market
- 0Share of holdings soldSold 5.6% of holdings
- +8Cluster2 insiders selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -8.6%, 3m -5.3%, 6m -7.0%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000950170-24-125616, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 8, 2024 | SOpen-market sale Common Stock | -8,108 | $16.00 | $130k | 135,810 | Nov 12, 2024 |
Related signals
Other insiders at Pediatrix Medical Group, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 58Moderate | MDsell Pediatrix Medical Group, Inc. | Shirley A Weis director | $856k 36,028 shares | -100% | |
| 43Moderate | MDsell Pediatrix Medical Group, Inc. | Mark S Ordan Chief Executive Officer | $515k 23,000 shares | -7% | |
| 41Moderate | Pediatrix Medical Group, Inc. | Michael A. Rucker director | $241k 10,478 shares | -15% | |
| 40Moderate | Pediatrix Medical Group, Inc. | Laura A Linynsky director | $217k 10,000 shares | -24% | |
| 44Moderate | Pediatrix Medical Group, Inc. | Mark S Ordan Chief Executive Officer | $424k 27,600 shares | -17% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.